AVNS Q4 2022 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$182M-6.1% YoY

Gross Profit

$103M56.7% margin

Operating Income

$17M9.6% margin

Net Income

$17M9.3% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$496M

Stockholders' Equity

$1.3B

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182M	$193M	-6.1%
Gross Profit	$103M	$98M	+5.2%
Operating Income	$17M	$19M	-9.4%
Net Income	$17M	$10M	+69.0%

Revenue Segments

Chronic Care

$129M30%

Digestive health

$93M21%

Pain Management

$89M20%

Interventional pain

$47M11%

Acute pain

$41M9%

Respiratory health

$36M8%